In conclusion, the results of this study indicate that germline protein-truncating mutations in the BRCA2 gene confer an elevated RR (almost eight-fold) of developing early-onset prostate cancer in Caucasian men. This evidence concerns the gene BRCA2 and Familial prostate cancer.